Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1991 Dec;67(794):1042–1054. doi: 10.1136/pgmj.67.794.1042

Clinical pharmacology and therapeutics.

R C Horton 1, M J Kendall 1
PMCID: PMC2399183  PMID: 1800962

Full text

PDF
1042

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Additional cases of suicidal ideation associated with fluoxetine. Am J Psychiatry. 1990 Nov;147(11):1570–1571. doi: 10.1176/ajp.147.11.aj147111570. [DOI] [PubMed] [Google Scholar]
  2. Altamura A. C., Mauri M. C., Girardi T., Panetta B. Alcoholism and depression: a placebo controlled study with viloxazine. Int J Clin Pharmacol Res. 1990;10(5):293–298. [PubMed] [Google Scholar]
  3. Arns P. A. Misoprostol. Am J Med Sci. 1991 Feb;301(2):133–137. doi: 10.1097/00000441-199102000-00008. [DOI] [PubMed] [Google Scholar]
  4. Bardhan K. D., Naesdal J., Bianchi Porro G., Petrillo M., Lazzaroni M., Hinchliffe R. F., Thompson M., Morris P., Daly M. J., Carroll N. J. Treatment of refractory peptic ulcer with omeprazole or continued H2 receptor antagonists: a controlled clinical trial. Gut. 1991 Apr;32(4):435–438. doi: 10.1136/gut.32.4.435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bate C. M., Keeling P. W., O'Morain C., Wilkinson S. P., Foster D. N., Mountford R. A., Temperley J. M., Harvey R. F., Thompson D. G., Davis M. Comparison of omeprazole and cimetidine in reflux oesophagitis: symptomatic, endoscopic, and histological evaluations. Gut. 1990 Sep;31(9):968–972. doi: 10.1136/gut.31.9.968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Blum H. E., Galun E., von Weizsäcker F., Wands J. R. Inhibition of hepatitis B virus by antisense oligodeoxynucleotides. Lancet. 1991 May 18;337(8751):1230–1230. doi: 10.1016/0140-6736(91)92907-j. [DOI] [PubMed] [Google Scholar]
  7. Borison R. L., Diamond B. I. New advances in psychotherapeutic agents: clozapine. Psychiatr Med. 1990;8(4):13–21. [PubMed] [Google Scholar]
  8. Brahams D. Libel suit over letter to the editor. Lancet. 1991 Jun 8;337(8754):1403–1404. doi: 10.1016/0140-6736(91)93077-m. [DOI] [PubMed] [Google Scholar]
  9. Burkart F., Pfisterer M., Kiowski W., Follath F., Burckhardt D. Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel Antiarrhythmic Study of Infarct Survival (BASIS) J Am Coll Cardiol. 1990 Dec;16(7):1711–1718. doi: 10.1016/0735-1097(90)90324-i. [DOI] [PubMed] [Google Scholar]
  10. Butler A., Hill J. M., Ireland S. J., Jordan C. C., Tyers M. B. Pharmacological properties of GR38032F, a novel antagonist at 5-HT3 receptors. Br J Pharmacol. 1988 Jun;94(2):397–412. doi: 10.1111/j.1476-5381.1988.tb11542.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Cady R. K., Wendt J. K., Kirchner J. R., Sargent J. D., Rothrock J. F., Skaggs H., Jr Treatment of acute migraine with subcutaneous sumatriptan. JAMA. 1991 Jun 5;265(21):2831–2835. [PubMed] [Google Scholar]
  12. Camilleri M., Fealey R. D. Idiopathic autonomic denervation in eight patients presenting with functional gastrointestinal disease. A causal association? Dig Dis Sci. 1990 May;35(5):609–616. doi: 10.1007/BF01540409. [DOI] [PubMed] [Google Scholar]
  13. Chapman N. D., Grillage M. G., Mazumder R., Atkinson S. N. A comparison of mebeverine with high-fibre dietary advice and mebeverine plus ispaghula in the treatment of irritable bowel syndrome: an open, prospectively randomised, parallel group study. Br J Clin Pract. 1990 Nov;44(11):461–466. [PubMed] [Google Scholar]
  14. Coyle J. T., Price D. L., DeLong M. R. Alzheimer's disease: a disorder of cortical cholinergic innervation. Science. 1983 Mar 11;219(4589):1184–1190. doi: 10.1126/science.6338589. [DOI] [PubMed] [Google Scholar]
  15. Crapper McLachlan D. R., Dalton A. J., Kruck T. P., Bell M. Y., Smith W. L., Kalow W., Andrews D. F. Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet. 1991 Jun 1;337(8753):1304–1308. doi: 10.1016/0140-6736(91)92978-b. [DOI] [PubMed] [Google Scholar]
  16. Crosignani A., Battezzati P. M., Setchell K. D., Camisasca M., Bertolini E., Roda A., Zuin M., Podda M. Effects of ursodeoxycholic acid on serum liver enzymes and bile acid metabolism in chronic active hepatitis: a dose-response study. Hepatology. 1991 Feb;13(2):339–344. [PubMed] [Google Scholar]
  17. Cross A. J. Serotonin in Alzheimer-type dementia and other dementing illnesses. Ann N Y Acad Sci. 1990;600:405–417. doi: 10.1111/j.1749-6632.1990.tb16897.x. [DOI] [PubMed] [Google Scholar]
  18. Curran D. A., Hinterberger H., Lance J. W. Total plasma serotonin, 5-hydroxyindoleacetic acid and p-hydroxy-m-methoxymandelic acid excretion in normal and migrainous subjects. Brain. 1965 Dec;88(5):997–1010. doi: 10.1093/brain/88.5.997. [DOI] [PubMed] [Google Scholar]
  19. Curzon G., Barrie M., Wilkinson M. I. Relationships between headache and amine changes after administration of reserpine to migrainous patients. J Neurol Neurosurg Psychiatry. 1969 Dec;32(6):555–561. doi: 10.1136/jnnp.32.6.555. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Davidson M., Zemishlany Z., Mohs R. C., Horvath T. B., Powchik P., Blass J. P., Davis K. L. 4-Aminopyridine in the treatment of Alzheimer's disease. Biol Psychiatry. 1988 Mar 1;23(5):485–490. doi: 10.1016/0006-3223(88)90020-0. [DOI] [PubMed] [Google Scholar]
  21. Davis G. L., Balart L. A., Schiff E. R., Lindsay K., Bodenheimer H. C., Jr, Perrillo R. P., Carey W., Jacobson I. M., Payne J., Dienstag J. L. Treatment of chronic hepatitis C with recombinant alpha-interferon. A multicentre randomized, controlled trial. The Hepatitis Interventional Therapy Group. J Hepatol. 1990;11 (Suppl 1):S31–S35. doi: 10.1016/0168-8278(90)90160-s. [DOI] [PubMed] [Google Scholar]
  22. Davis K. L., Mohs R. C. Enhancement of memory processes in Alzheimer's disease with multiple-dose intravenous physostigmine. Am J Psychiatry. 1982 Nov;139(11):1421–1424. doi: 10.1176/ajp.139.11.1421. [DOI] [PubMed] [Google Scholar]
  23. De Mulder P. H., Seynaeve C., Vermorken J. B., van Liessum P. A., Mols-Jevdevic S., Allman E. L., Beranek P., Verweij J. Ondansetron compared with high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting. A multicenter, randomized, double-blind, crossover study. Ann Intern Med. 1990 Dec 1;113(11):834–840. doi: 10.7326/0003-4819-113-11-834. [DOI] [PubMed] [Google Scholar]
  24. Dehn T. C., Shepherd H. A., Colin-Jones D., Kettlewell M. G., Carroll N. J. Double blind comparison of omeprazole (40 mg od) versus cimetidine (400 mg qd) in the treatment of symptomatic erosive reflux oesophagitis, assessed endoscopically, histologically and by 24 h pH monitoring. Gut. 1990 May;31(5):509–513. doi: 10.1136/gut.31.5.509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Delcker A., Schoon M. L., Oczkowski B., Gaertner H. J. Amisulpride versus haloperidol in treatment of schizophrenic patients--results of a double-blind study. Pharmacopsychiatry. 1990 May;23(3):125–130. doi: 10.1055/s-2007-1014494. [DOI] [PubMed] [Google Scholar]
  26. Dellsperger K. C., Martins J. B., Clothier J. L., Marcus M. L. Incidence of sudden cardiac death associated with coronary artery occlusion in dogs with hypertension and left ventricular hypertrophy is reduced by chronic beta-adrenergic blockade. Circulation. 1990 Sep;82(3):941–950. doi: 10.1161/01.cir.82.3.941. [DOI] [PubMed] [Google Scholar]
  27. Deltito J. A., Argyle N., Klerman G. L. Patients with panic disorder unaccompanied by depression improve with alprazolam and imipramine treatment. J Clin Psychiatry. 1991 Mar;52(3):121–127. [PubMed] [Google Scholar]
  28. Depoortere I., Peeters T. L., Vantrappen G. Development of motilin receptors and of motilin- and erythromycin-induced contractility in rabbits. Gastroenterology. 1990 Sep;99(3):652–658. doi: 10.1016/0016-5085(90)90951-v. [DOI] [PubMed] [Google Scholar]
  29. Doenicke A., Brand J., Perrin V. L. Possible benefit of GR43175, a novel 5-HT1-like receptor agonist, for the acute treatment of severe migraine. Lancet. 1988 Jun 11;1(8598):1309–1311. doi: 10.1016/s0140-6736(88)92122-8. [DOI] [PubMed] [Google Scholar]
  30. Eagger S. A., Levy R., Sahakian B. J. Tacrine in Alzheimer's disease. Lancet. 1991 Apr 27;337(8748):989–992. doi: 10.1016/0140-6736(91)92656-m. [DOI] [PubMed] [Google Scholar]
  31. Echt D. S., Liebson P. R., Mitchell L. B., Peters R. W., Obias-Manno D., Barker A. H., Arensberg D., Baker A., Friedman L., Greene H. L. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med. 1991 Mar 21;324(12):781–788. doi: 10.1056/NEJM199103213241201. [DOI] [PubMed] [Google Scholar]
  32. Etienne P., Dastoor D., Gauthier S., Ludwick R., Collier B. Alzheimer disease: lack of effect of lecithin treatment for 3 months. Neurology. 1981 Dec;31(12):1552–1554. doi: 10.1212/wnl.31.12.1552. [DOI] [PubMed] [Google Scholar]
  33. Fabre L. F. Buspirone in the management of major depression: a placebo-controlled comparison. J Clin Psychiatry. 1990 Sep;51 (Suppl):55–61. [PubMed] [Google Scholar]
  34. Fava M., Rosenbaum J. F. Suicidality and fluoxetine: is there a relationship? J Clin Psychiatry. 1991 Mar;52(3):108–111. [PubMed] [Google Scholar]
  35. Feighner J. P., Boyer W. F. Paroxetine in the treatment of depression: a comparison with imipramine and placebo. Acta Psychiatr Scand Suppl. 1989;350:125–129. doi: 10.1111/j.1600-0447.1989.tb07190.x. [DOI] [PubMed] [Google Scholar]
  36. Feniuk W., Humphrey P. P., Perren M. J. The selective carotid arterial vasoconstrictor action of GR43175 in anaesthetized dogs. Br J Pharmacol. 1989 Jan;96(1):83–90. doi: 10.1111/j.1476-5381.1989.tb11787.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Fontaine R., Beaudry P., Le Morvan P., Beauclair L., Chouinard G. Zopiclone and triazolam in insomnia associated with generalized anxiety disorder: a placebo-controlled evaluation of efficacy and daytime anxiety. Int Clin Psychopharmacol. 1990 Jul;5(3):173–183. doi: 10.1097/00004850-199007000-00002. [DOI] [PubMed] [Google Scholar]
  38. Forsyth D. R., Surmon D. J., Morgan R. A., Wilcock G. K. Clinical experience with and side-effects of tacrine hydrochloride in Alzheimer's disease: a pilot study. Age Ageing. 1989 Jul;18(4):223–229. doi: 10.1093/ageing/18.4.223. [DOI] [PubMed] [Google Scholar]
  39. Fowler P. A., Lacey L. F., Thomas M., Keene O. N., Tanner R. J., Baber N. S. The clinical pharmacology, pharmacokinetics and metabolism of sumatriptan. Eur Neurol. 1991;31(5):291–294. doi: 10.1159/000116756. [DOI] [PubMed] [Google Scholar]
  40. Friberg L., Olesen J., Iversen H. K., Sperling B. Migraine pain associated with middle cerebral artery dilatation: reversal by sumatriptan. Lancet. 1991 Jul 6;338(8758):13–17. doi: 10.1016/0140-6736(91)90005-a. [DOI] [PubMed] [Google Scholar]
  41. Galmiche J. P., Fraitag B., Filoche B., Evreux M., Vitaux J., Zeitoun P., Fournet J., Soule J. C. Double-blind comparison of cisapride and cimetidine in treatment of reflux esophagitis. Dig Dis Sci. 1990 May;35(5):649–655. doi: 10.1007/BF01540415. [DOI] [PubMed] [Google Scholar]
  42. Glise H., Martinson J., Solhaug J. H., Carling L., Unge P., Engström G., Hallerbäck B. Two and four weeks' treatment for duodenal ulcer. Symptom relief and clinical remission comparing omeprazole and ranitidine. Scandinavian Clinics for United Research. Scand J Gastroenterol. 1991 Feb;26(2):137–145. doi: 10.3109/00365529109025023. [DOI] [PubMed] [Google Scholar]
  43. Gralla R. J., Itri L. M., Pisko S. E., Squillante A. E., Kelsen D. P., Braun D. W., Jr, Bordin L. A., Braun T. J., Young C. W. Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting. N Engl J Med. 1981 Oct 15;305(16):905–909. doi: 10.1056/NEJM198110153051601. [DOI] [PubMed] [Google Scholar]
  44. Griffith M. J., Linker N. J., Garratt C. J., Ward D. E., Camm A. J. Relative efficacy and safety of intravenous drugs for termination of sustained ventricular tachycardia. Lancet. 1990 Sep 15;336(8716):670–673. doi: 10.1016/0140-6736(90)92158-e. [DOI] [PubMed] [Google Scholar]
  45. Harbaugh R. E., Roberts D. W., Coombs D. W., Saunders R. L., Reeder T. M. Preliminary report: intracranial cholinergic drug infusion in patients with Alzheimer's disease. Neurosurgery. 1984 Oct;15(4):514–518. doi: 10.1227/00006123-198410000-00007. [DOI] [PubMed] [Google Scholar]
  46. Hayes P. C., Davis J. M., Lewis J. A., Bouchier I. A. Meta-analysis of value of propranolol in prevention of variceal haemorrhage. Lancet. 1990 Jul 21;336(8708):153–156. doi: 10.1016/0140-6736(90)91668-z. [DOI] [PubMed] [Google Scholar]
  47. Hayllar J., Bjarnason I. Sulphasalazine in ulcerative colitis: in memoriam? Gut. 1991 May;32(5):462–463. doi: 10.1136/gut.32.5.462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Hernandez M., Reder R. F., Marinchak R. A., Rials S. J., Kowey P. R. Propafenone for malignant ventricular arrhythmia: an analysis of the literature. Am Heart J. 1991 Apr;121(4 Pt 1):1178–1184. doi: 10.1016/0002-8703(91)90680-g. [DOI] [PubMed] [Google Scholar]
  49. Hogan W. J. Gastroesophageal reflux disease: an update on management. J Clin Gastroenterol. 1990;12 (Suppl 2):S21–S28. [PubMed] [Google Scholar]
  50. Hoofnagle J. H. Alpha-interferon therapy of chronic hepatitis B. Current status and recommendations. J Hepatol. 1990;11 (Suppl 1):S100–S107. doi: 10.1016/0168-8278(90)90173-o. [DOI] [PubMed] [Google Scholar]
  51. Humphrey P. P., Feniuk W., Perren M. J., Beresford I. J., Skingle M., Whalley E. T. Serotonin and migraine. Ann N Y Acad Sci. 1990;600:587–600. doi: 10.1111/j.1749-6632.1990.tb16912.x. [DOI] [PubMed] [Google Scholar]
  52. Janssens J., Peeters T. L., Vantrappen G., Tack J., Urbain J. L., De Roo M., Muls E., Bouillon R. Improvement of gastric emptying in diabetic gastroparesis by erythromycin. Preliminary studies. N Engl J Med. 1990 Apr 12;322(15):1028–1031. doi: 10.1056/NEJM199004123221502. [DOI] [PubMed] [Google Scholar]
  53. Jenike M. A., Baer L., Buttolph L. Buspirone augmentation of fluoxetine in patients with obsessive compulsive disorder. J Clin Psychiatry. 1991 Jan;52(1):13–14. [PubMed] [Google Scholar]
  54. KIMBALL R. W., FRIEDMAN A. P., VALLEJO E. Effect of serotonin in migraine patients. Neurology. 1960 Feb;10:107–111. doi: 10.1212/wnl.10.2.107. [DOI] [PubMed] [Google Scholar]
  55. Kane J., Honigfeld G., Singer J., Meltzer H. Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch Gen Psychiatry. 1988 Sep;45(9):789–796. doi: 10.1001/archpsyc.1988.01800330013001. [DOI] [PubMed] [Google Scholar]
  56. Kellow J. E., Gill R. C., Wingate D. L. Prolonged ambulant recordings of small bowel motility demonstrate abnormalities in the irritable bowel syndrome. Gastroenterology. 1990 May;98(5 Pt 1):1208–1218. doi: 10.1016/0016-5085(90)90335-x. [DOI] [PubMed] [Google Scholar]
  57. Kendall M. J., Horton R. C. Clinical pharmacology and therapeutics. Postgrad Med J. 1990 Mar;66(773):166–185. doi: 10.1136/pgmj.66.773.166. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Kilpatrick G. J., Jones B. J., Tyers M. B. Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding. Nature. 1987 Dec 24;330(6150):746–748. doi: 10.1038/330746a0. [DOI] [PubMed] [Google Scholar]
  59. Knill-Jones R., Drummond M., Kohli H., Davies L. Economic evaluation of gastric ulcer prophylaxis in patients with arthritis receiving non-steroidal anti-inflammatory drugs. Postgrad Med J. 1990 Aug;66(778):639–646. doi: 10.1136/pgmj.66.778.639. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Koop H., Hotz J., Pommer G., Klein M., Arnold R. Prospective evaluation of omeprazole treatment in reflux oesophagitis refractory to H2-receptor antagonists. Aliment Pharmacol Ther. 1990 Dec;4(6):593–599. doi: 10.1111/j.1365-2036.1990.tb00507.x. [DOI] [PubMed] [Google Scholar]
  61. Lauritsen K., Andersen B. N., Laursen L. S., Hansen J., Havelund T., Eriksen J., Rehfeld J. F., Kjaergaard J., Rask-Madsen J. Omeprazole 20 mg three days a week and 10 mg daily in prevention of duodenal ulcer relapse. Double-blind comparative trial. Gastroenterology. 1991 Mar;100(3):663–669. doi: 10.1016/0016-5085(91)80009-x. [DOI] [PubMed] [Google Scholar]
  62. Lee F. I., Hardman M., Jaderberg M. E. Maintenance treatment of duodenal ulceration: ranitidine 300 mg at night is better than 150 mg in cigarette smokers. Gut. 1991 Feb;32(2):151–153. doi: 10.1136/gut.32.2.151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Leuschner U., Fischer H., Kurtz W., Güldütuna S., Hübner K., Hellstern A., Gatzen M., Leuschner M. Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial. Gastroenterology. 1989 Nov;97(5):1268–1274. doi: 10.1016/0016-5085(89)91698-3. [DOI] [PubMed] [Google Scholar]
  64. Lieberman J. A., Yunis J., Egea E., Canoso R. T., Kane J. M., Yunis E. J. HLA-B38, DR4, DQw3 and clozapine-induced agranulocytosis in Jewish patients with schizophrenia. Arch Gen Psychiatry. 1990 Oct;47(10):945–948. doi: 10.1001/archpsyc.1990.01810220061007. [DOI] [PubMed] [Google Scholar]
  65. Mann H. J. Moricizine: a new class I antiarrhythmic. Clin Pharm. 1990 Nov;9(11):842–852. [PubMed] [Google Scholar]
  66. Marty M. A comparative study of the use of granisetron, a selective 5-HT3 antagonist, versus a standard anti-emetic regimen of chlorpromazine plus dexamethasone in the treatment of cytostatic-induced emesis. The Granisetron Study Group. Eur J Cancer. 1990;26 (Suppl 1):S28–S32. [PubMed] [Google Scholar]
  67. Marty M. Ondansetron in the prophylaxis of acute cisplatin-induced nausea and vomiting. Eur J Cancer Clin Oncol. 1989;25 (Suppl 1):S41–S45. [PubMed] [Google Scholar]
  68. Marty M., Pouillart P., Scholl S., Droz J. P., Azab M., Brion N., Pujade-Lauraine E., Paule B., Paes D., Bons J. Comparison of the 5-hydroxytryptamine3 (serotonin) antagonist ondansetron (GR 38032F) with high-dose metoclopramide in the control of cisplatin-induced emesis. N Engl J Med. 1990 Mar 22;322(12):816–821. doi: 10.1056/NEJM199003223221205. [DOI] [PubMed] [Google Scholar]
  69. Masand P., Gupta S., Dewan M. Suicidal ideation related to fluoxetine treatment. N Engl J Med. 1991 Feb 7;324(6):420–420. doi: 10.1056/nejm199102073240616. [DOI] [PubMed] [Google Scholar]
  70. McCarthy D. M. NSAID-induced gastrointestinal damage. A critical review of prophylaxis and therapy. J Clin Gastroenterol. 1990;12 (Suppl 2):S13–S20. [PubMed] [Google Scholar]
  71. McFarland R. J., Bateson M. C., Green J. R., O'Donoghue D. P., Dronfield M. W., Keeling P. W., Burke G. J., Dickinson R. J., Shreeve D. R., Peers E. M. Omeprazole provides quicker symptom relief and duodenal ulcer healing than ranitidine. Gastroenterology. 1990 Feb;98(2):278–283. doi: 10.1016/0016-5085(90)90815-i. [DOI] [PubMed] [Google Scholar]
  72. Moertel C. G., Reitemeier R. J. Controlled clinical studies of orally administered antiemetic drugs. Gastroenterology. 1969 Sep;57(3):262–268. [PubMed] [Google Scholar]
  73. Moises H. W., Gelernter J., Giuffra L. A., Zarcone V., Wetterberg L., Civelli O., Kidd K. K., Cavalli-Sforza L. L., Grandy D. K., Kennedy J. L. No linkage between D2 dopamine receptor gene region and schizophrenia. Arch Gen Psychiatry. 1991 Jul;48(7):643–647. doi: 10.1001/archpsyc.1991.01810310061011. [DOI] [PubMed] [Google Scholar]
  74. Molloy D. W., Guyatt G. H., Wilson D. B., Duke R., Rees L., Singer J. Effect of tetrahydroaminoacridine on cognition, function and behaviour in Alzheimer's disease. CMAJ. 1991 Jan 1;144(1):29–34. [PMC free article] [PubMed] [Google Scholar]
  75. Mozwecz H., Pavel D., Pitrak D., Orellana P., Schlesinger P. K., Layden T. J. Erythromycin stearate as prokinetic agent in postvagotomy gastroparesis. Dig Dis Sci. 1990 Jul;35(7):902–905. doi: 10.1007/BF01536806. [DOI] [PubMed] [Google Scholar]
  76. Murray D. P., Murray R. G., Littler W. A. The effects of metoprolol given early in acute myocardial infarction on ventricular arrhythmias. Eur Heart J. 1986 Mar;7(3):217–222. doi: 10.1093/oxfordjournals.eurheartj.a062054. [DOI] [PubMed] [Google Scholar]
  77. Ngen C. C., Hassan R. A double-blind placebo-controlled trial of zopiclone 7.5 mg and temazepam 20 mg in insomnia. Int Clin Psychopharmacol. 1990 Jul;5(3):165–171. doi: 10.1097/00004850-199007000-00001. [DOI] [PubMed] [Google Scholar]
  78. O'Brien J. T., Eagger S., Levy R. Effects of tetrahydroaminoacridine on liver function in patients with Alzheimer's disease. Age Ageing. 1991 Mar;20(2):129–131. doi: 10.1093/ageing/20.2.129. [DOI] [PubMed] [Google Scholar]
  79. O'Donnell L. J., Watson A. J., Cameron D., Farthing M. J. Effect of octreotide on mouth-to-caecum transit time in healthy subjects and in the irritable bowel syndrome. Aliment Pharmacol Ther. 1990 Apr;4(2):177–181. doi: 10.1111/j.1365-2036.1990.tb00463.x. [DOI] [PubMed] [Google Scholar]
  80. Parker G. W., Michael L. H., Hartley C. J., Skinner J. E., Entman M. L. Central beta-adrenergic mechanisms may modulate ischemic ventricular fibrillation in pigs. Circ Res. 1990 Feb;66(2):259–270. doi: 10.1161/01.res.66.2.259. [DOI] [PubMed] [Google Scholar]
  81. Pato M. T., Pigott T. A., Hill J. L., Grover G. N., Bernstein S., Murphy D. L. Controlled comparison of buspirone and clomipramine in obsessive-compulsive disorder. Am J Psychiatry. 1991 Jan;148(1):127–129. doi: 10.1176/ajp.148.1.127. [DOI] [PubMed] [Google Scholar]
  82. Perry E. K., Perry R. H., Blessed G., Tomlinson B. E. Necropsy evidence of central cholinergic deficits in senile dementia. Lancet. 1977 Jan 22;1(8004):189–189. doi: 10.1016/s0140-6736(77)91780-9. [DOI] [PubMed] [Google Scholar]
  83. Perry E. K. The cholinergic hypothesis--ten years on. Br Med Bull. 1986 Jan;42(1):63–69. doi: 10.1093/oxfordjournals.bmb.a072100. [DOI] [PubMed] [Google Scholar]
  84. Peters B. H., Levin H. S. Effects of physostigmine and lecithin on memory in Alzheimer disease. Ann Neurol. 1979 Sep;6(3):219–221. doi: 10.1002/ana.410060307. [DOI] [PubMed] [Google Scholar]
  85. Pigott T. A., Pato M. T., Bernstein S. E., Grover G. N., Hill J. L., Tolliver T. J., Murphy D. L. Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Behavioral and biological results. Arch Gen Psychiatry. 1990 Oct;47(10):926–932. doi: 10.1001/archpsyc.1990.01810220042005. [DOI] [PubMed] [Google Scholar]
  86. Priestman T. J. Clinical studies with ondansetron in the control of radiation-induced emesis. Eur J Cancer Clin Oncol. 1989;25 (Suppl 1):S29–S33. [PubMed] [Google Scholar]
  87. Propafenone: an antiarrhythmic come in from the cold. Lancet. 1989 Dec 23;2(8678-8679):1490–1491. [PubMed] [Google Scholar]
  88. Rankin A. C., McGovern B. A. Adenosine or verapamil for the acute treatment of supraventricular tachycardia? Ann Intern Med. 1991 Mar 15;114(6):513–515. doi: 10.7326/0003-4819-114-6-513. [DOI] [PubMed] [Google Scholar]
  89. Raskin N. H. Serotonin receptors and headache. N Engl J Med. 1991 Aug 1;325(5):353–354. doi: 10.1056/NEJM199108013250509. [DOI] [PubMed] [Google Scholar]
  90. Rauws E. A., Tytgat G. N. Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet. 1990 May 26;335(8700):1233–1235. doi: 10.1016/0140-6736(90)91301-p. [DOI] [PubMed] [Google Scholar]
  91. Reichard O., Andersson J., Schvarcz R., Weiland O. Ribavirin treatment for chronic hepatitis C. Lancet. 1991 May 4;337(8749):1058–1061. doi: 10.1016/0140-6736(91)91707-2. [DOI] [PubMed] [Google Scholar]
  92. Rickels K., Amsterdam J., Clary C., Hassman J., London J., Puzzuoli G., Schweizer E. Buspirone in depressed outpatients: a controlled study. Psychopharmacol Bull. 1990;26(2):163–167. [PubMed] [Google Scholar]
  93. Rydén L., Ariniego R., Arnman K., Herlitz J., Hjalmarson A., Holmberg S., Reyes C., Smedgård P., Svedberg K., Vedin A. A double-blind trial of metoprolol in acute myocardial infarction. Effects on ventricular tachyarrhythmias. N Engl J Med. 1983 Mar 17;308(11):614–618. doi: 10.1056/NEJM198303173081102. [DOI] [PubMed] [Google Scholar]
  94. Schmoll H. J. The role of ondansetron in the treatment of emesis induced by non-cisplatin-containing chemotherapy regimes. Eur J Cancer Clin Oncol. 1989;25 (Suppl 1):S35–S39. [PubMed] [Google Scholar]
  95. Staerk Laursen L., Stokholm M., Bukhave K., Rask-Madsen J., Lauritsen K. Disposition of 5-aminosalicylic acid by olsalazine and three mesalazine preparations in patients with ulcerative colitis: comparison of intraluminal colonic concentrations, serum values, and urinary excretion. Gut. 1990 Nov;31(11):1271–1276. doi: 10.1136/gut.31.11.1271. [DOI] [PMC free article] [PubMed] [Google Scholar]
  96. Staumont G., Fioramonti J., Frexinos J., Bueno L. Oral prostaglandin E analogues induce intestinal migrating motor complexes after a meal in dogs. Evidence for a central mechanism. Gastroenterology. 1990 Apr;98(4):888–893. doi: 10.1016/0016-5085(90)90012-p. [DOI] [PubMed] [Google Scholar]
  97. Teicher M. H., Glod C., Cole J. O. Emergence of intense suicidal preoccupation during fluoxetine treatment. Am J Psychiatry. 1990 Feb;147(2):207–210. doi: 10.1176/ajp.147.2.207. [DOI] [PubMed] [Google Scholar]
  98. Terés J., Planas R., Panes J., Salmeron J. M., Mas A., Bosch J., Llorente C., Viver J., Feu F., Rodés J. Vasopressin/nitroglycerin infusion vs. esophageal tamponade in the treatment of acute variceal bleeding: a randomized controlled trial. Hepatology. 1990 Jun;11(6):964–968. doi: 10.1002/hep.1840110609. [DOI] [PubMed] [Google Scholar]
  99. Thal L. J., Rosen W., Sharpless N. S., Crystal H. Choline chloride in Alzheimer disease. Ann Neurol. 1981 Dec;10(6):580–580. doi: 10.1002/ana.410100617. [DOI] [PubMed] [Google Scholar]
  100. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med. 1981 Apr 2;304(14):801–807. doi: 10.1056/NEJM198104023041401. [DOI] [PubMed] [Google Scholar]
  101. Triozzi P. L., Laszlo J. Optimum management of nausea and vomiting in cancer chemotherapy. Drugs. 1987 Jul;34(1):136–149. doi: 10.2165/00003495-198734010-00005. [DOI] [PubMed] [Google Scholar]
  102. Van Outryve M., Milo R., Toussaint J., Van Eeghem P. "Prokinetic" treatment of constipation-predominant irritable bowel syndrome: a placebo-controlled study of cisapride. J Clin Gastroenterol. 1991 Feb;13(1):49–57. doi: 10.1097/00004836-199102000-00012. [DOI] [PubMed] [Google Scholar]
  103. Wadworth A. N., Heel R. C. Remoxipride. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in schizophrenia. Drugs. 1990 Dec;40(6):863–879. doi: 10.2165/00003495-199040060-00008. [DOI] [PubMed] [Google Scholar]
  104. Whalley L. J. Drug treatments of dementia. Br J Psychiatry. 1989 Nov;155:595–611. doi: 10.1192/s0007125000018079. [DOI] [PubMed] [Google Scholar]
  105. Wiesner R. H., Ludwig J., Lindor K. D., Jorgensen R. A., Baldus W. P., Homburger H. A., Dickson E. R. A controlled trial of cyclosporine in the treatment of primary biliary cirrhosis. N Engl J Med. 1990 May 17;322(20):1419–1424. doi: 10.1056/NEJM199005173222003. [DOI] [PubMed] [Google Scholar]
  106. de Kaski M. C., Peters A. M., Lavender J. P., Hodgson H. J. Fluticasone propionate in Crohn's disease. Gut. 1991 Jun;32(6):657–661. doi: 10.1136/gut.32.6.657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  107. von Bahr C., Wiesel F. A., Movin G., Eneroth P., Jansson P., Nilsson L., Ogenstad S. Neuroendocrine responses to single oral doses of remoxipride and sulpiride in healthy female and male volunteers. Psychopharmacology (Berl) 1991;103(4):443–448. doi: 10.1007/BF02244242. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES